November 21, 2003. One concern about Hylaform is the lack of data for African Americans and Asian Americans. Only three of the patients are African American and only five are Asian American.
Read More »On Medical Treatments & Products
NCHR Testimony at FDA on Restylane
November 21, 2003. It is clear that both women and men alike continue to search for the fountain of youth. We know that these products are widely used, and that’s why they should be carefully studied. They should be approved if they are safe and effective.
Read More »Testimony at FDA on Silicone Gel Breast Implants
October 15, 2003. The FDA’s study, described by Dr. Lori Brown yesterday, is the best designed study ever conducted on the topic. One reason for its superiority is that it focused on women who were basically happy with their implants, and who had implants for at least 7 years.
Read More »Comment On Dietary Supplements Containing Ephedrine
April 23, 2003. At this time, there is little evidence suggesting that ephedra is effective for weight loss, unless used in conjunction with strategies that are effective without ephedra.
Read More »NCHR Testimony at FDA on Artecoll
February 28, 2003. If FDA approval is to mean anything, it should mean that the benefits outweigh the risks. The benefits are purely cosmetic, and most are not statistically-significant. We don’t know exactly what the risks are yet.
Read More »